Almirall (WBO:ALM) Short Percentage of Float

View and export this data going back to 2022. Start your Free Trial

What is Almirall Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Almirall's Short Percentage of Float

For the Drug Manufacturers - Specialty & Generic subindustry, Almirall's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Almirall's Short Percentage of Float Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Almirall's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Almirall's Short Percentage of Float falls into.

Almirall (WBO:ALM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Almirall SA (WBO:ALM) » Definitions » Short Percentage of Float

Comparable Companies

Traded in Other Exchanges

LBTSF:USA 0O9B:UK ALM:Spain E2Z:Germany

Address

Ronda General Mitre 151, Barcelona, ESP, 08022

Website

http://www.almirall.es

Almirall SA is a Spain-based company engaged in development, manufacture, and selling pharmaceutical products across a range of therapeutic areas. It aims to provide treatments in areas of dermatology, respiratory, gastrointestinal, central nervous systems, and other specialties. The company operates in five segments: Sales of its own network, sales of licensees, Research and developments, Sales of Therapeutic dermatological products in the U.S., and Corporate management. The medical dermatology business in the Europe is the key driver of the company's operation. Other than Europe, the company also operates in the Americas, Asia, Africa, and Oceania through subsidiaries.

Almirall (WBO:ALM) Headlines

From GuruFocus

Alfi: Solid Growth Potential Lies Ahead

By Ishan Majumdar Ishan Majumdar • 06-02-2021

ALFI Inc: A Little Known Yet Compelling Ad-Tech Play

By Ishan Majumdar Ishan Majumdar • 05-07-2021